搜尋
LAVA Therapeutics NV
LVTX添加自選
1.740USD
0.0000.00%
收盤 07/02, 16:00（美東）報價延遲15分鐘
45.77M總市值
虧損本益比TTM
關於 LAVA Therapeutics NV 公司
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA Therapeutics NV簡介
公司代碼LVTX
公司名稱LAVA Therapeutics NV
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
員工數量34
證券類型Ordinary Share
年結日Mar 25
公司地址Yalelaan 60
城市UTRECHT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Netherlands
郵編3584 CM
電話31850163100
網址https://www.lavatherapeutics.com/
公司代碼LVTX
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
LAVA Therapeutics NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
-100.00%
Mr. Edward F. Smith
Mr. Edward F. Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
常見問題
LAVA Therapeutics NV的前五大股東是誰？
LAVA Therapeutics NV的前五大股東如下：Dr. Kapil Dhingra, M.D.
有多少機構持有LAVA Therapeutics NV(LVTX)的股份？
截至2025Q4，共有49家機構持有LAVA Therapeutics NV的股份，合計持有的股份價值約為7.26M，占公司總股份的27.59% 。與2025Q3相比，機構持股有所增加，增幅為-4778197.00。